Department of Neurology, Kyoto Second Red Cross Hospital, Kyoto, Japan.
Eur Neurol. 2013;69(1):4-7. doi: 10.1159/000341339. Epub 2012 Nov 1.
A substantial proportion of patients who did not receive intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA), solely because of mild symptoms, can show poor outcome. The aim of our study was to analyze clinical and radiological features of the patients.
We enrolled 72 patients between 2007 and 2009 who presented to our hospital within 3 h after stroke onset and who did not receive rtPA therapy solely because of mild symptoms (NIHSS score of ≤ 4 at rtPA decision), and examined detailed characteristics of patients with poor outcomes. Poor outcome was defined as a modified Rankin Scale score of ≥ 2 at 3 months after the stroke.
Eleven of 72 patients (15%) had poor outcomes. Major vessel occlusion was observed in 7 of the 11 patients. Neurological deterioration after admission was main reason for poor outcome. Infarct expansion in 6 patients (2 large artery diseases and 4 small vessel diseases) and distal embolism by clot migration in 3 patients led to neurological deterioration.
Clinical and radiological features of mild stroke patients with poor outcomes, who did not receive rtPA therapy, were identified. In such patients, intravenous thrombolysis may be justified.
相当一部分未接受重组组织型纤溶酶原激活物(rtPA)静脉溶栓治疗的患者,仅仅因为症状轻微,预后较差。本研究旨在分析这些患者的临床和影像学特征。
我们纳入了 2007 年至 2009 年期间发病 3 h 内来我院就诊且因症状轻微(rtPA 决策时 NIHSS 评分≤4)而未接受 rtPA 治疗的 72 例患者,并详细检查了预后不良患者的特征。预后不良定义为卒中后 3 个月改良 Rankin 量表评分≥2。
72 例患者中有 11 例(15%)预后不良。11 例患者中有 7 例存在大血管闭塞。入院后神经功能恶化是预后不良的主要原因。6 例患者发生梗死扩大(2 例大血管疾病和 4 例小血管疾病),3 例患者发生血栓迁移引起的远端栓塞,导致神经功能恶化。
确定了未接受 rtPA 治疗的症状轻微但预后不良的卒中患者的临床和影像学特征。在这些患者中,静脉溶栓可能是合理的。